Company

Orthocell Limited

Headquarters: Murdoch, WA, Australia

CEO: Mr. Paul Frederick Anderson

ASX: OCC -3.76%

Market Cap

A$73.3 Million

AUD as of July 1, 2024

US$48.8 Million

Market Cap History

Orthocell Limited market capitalization over time

Evolution of Orthocell Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Orthocell Limited

Detailed Description

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia and internationally. The company's principal products include CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. In addition, the company develops Striate+ for use in bone and soft tissue repair; SMRT Graft for use in to augment repair of rotator cuff tendinopathy and tear; and Remplir, a nerve wrap. Orthocell Limited was incorporated in 2006 and is based in Murdoch, Australia.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Orthocell Limited has the following listings and related stock indices.


Stock: ASX: OCC wb_incandescent

Details

Headquarters:

Murdoch University

Building 191 South Street

Murdoch, WA 6150

Australia

Phone: 61 8 9360 2888

Fax: 61 8 9360 2899